Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

<p>Supplementary Table 2. Complete table results for all patients (n=201) involved in baseline (C1D1) analysis.</p>

Enregistré dans:
Détails bibliographiques
Auteur principal: Javier Pascual (15018176) (author)
Autres auteurs: Miguel Gil-Gil (15052083) (author), Paula Proszek (17141889) (author), Christoph Zielinski (15054460) (author), Alistair Reay (17141892) (author), Manuel Ruiz-Borrego (15048425) (author), Rosalind Cutts (17141895) (author), Eva M. Ciruelos Gil (17141898) (author), Andrew Feber (15124144) (author), Montserrat Muñoz-Mateu (15054469) (author), Claire Swift (17141901) (author), Begoña Bermejo (15037896) (author), Jesus Herranz (15048443) (author), Mireia Margeli Vila (15054472) (author), Antonio Antón (15054475) (author), Zsuzsanna Kahan (17141904) (author), Tibor Csöszi (17141907) (author), Yuan Liu (15054484) (author), Daniel Fernandez-Garcia (17141910) (author), Isaac Garcia-Murillas (15018188) (author), Michael Hubank (15104113) (author), Nicholas C. Turner (17141913) (author), Miguel Martín (15011399) (author)
Publié: 2025
Sujets:
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Biomarkers
Circulating tumor cells/DNA/exosomes
Serum biomarkers
Breast Cancer
Translational Research
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:<p>Supplementary Table 2. Complete table results for all patients (n=201) involved in baseline (C1D1) analysis.</p>

Documents similaires